Medicinal Product Shortages - update - 1 March 2023

Notice type: Advisory

Date: 01/03/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Akineton 2mg Tablets

PA1253/001/001

Laboratorio Farmaceutico S.I.T.

Biperiden

Atorvastatin Mylan 40mg Film Coated Tablets

PA0577/118/003

McDermott Laboratories Ltd., T/A Gerard Laboratories

Atorvastatin

Bactroban 2% w/w Ointment

PA1077/094/001

GlaxoSmithKline (Ireland) Limited

Muripocin

Campto 20mg/mL Concentrate for Solution for Infusion - 2ml vial

PA0822/212/001

Pfizer Healthcare Ireland

Irinotecan

Flucloxacillin 2000 mg Powder for solution for injection/infusion

PA1862/003/004

Ibigen Srl

Flucloxacillin

Furosemide 10 mg/ml Solution for Injection or Infusion - 2ml presentation

PA2315/163/001

Accord Healthcare Ireland Ltd.

Furosemide

Lyclear 5% w/w Dermal Cream

PA1077/066/001

GlaxoSmithKline (Ireland) Limited

Permethrin

Lyrica 150mg Capsules

EU/1/04/279/018

Upjohn EESV

Pregabalin

Minims Artificial Tears 0.35% w/w + 0.44% w/w Eye Drops, Solution

PA23259/013/001

Bausch + Lomb Ireland Limited

Sodium chloride & hydroxyethylcellulose

Minims Chloramphenicol 0.5% Eye Drops

PA22698/006/001

Bausch + Lomb Ireland Limited

Chloramphenicol

Minims Phenylephrine 2.5% w/ Eye Drops

PA22698/013/002

Bausch + Lomb Ireland Limited

Phenylephrine

Plenvu Powder for Oral Solution

PA1336/005/001

Norgine B.V.

Various

Quetex XR 50mg Prolonged-Release Tablets

PA0711/258/001

Rowex Ltd

Quetiapine

RoActemra 162mg Solution for Injection in Pre-filled Syringe

EU/1/08/492/007

Roche Registration GmbH

Tocilizumab

Solian 200mg Tablets

PA0540/158/003

Sanofi-Aventis Ireland Limited T/A SANOFI

Amisulpride

Solpadeine Capsules - 32 pack

PA1186/011/002

Chefaro Ireland DAC

Paracetamol, codeine & caffeine

Tradol 50mg Effervescent Tablets

PA0074/094/001

Rowa Pharmaceuticals Limited

Tramadol

Xtex Oral Solution 250mg/5ml

PA0074/071/001

Rowa Pharmaceuticals Limited

Carbocysteine

Zanidip 20mg Film Coated Tablets

PA0812/001/002

Recordati Industria Chimica e Farmaceutica SpA

Lercanidipine

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

.

Product

Active Ingredient(s)

Atozet 10mg/40mg Film-Coated Tablets

PA23198/022/003

Organon Pharma (Ireland) Limited

Ezetimibe & atorvastatin

Ciplox 250mg Film-Coated Tablets

PA2315/100/001

Accord Healthcare Ireland Ltd

Ciprofloxacin

Gonal-F 75IU Powder and Solvent for Solution for Injection

EU/1/95/001/025

Merck Europe B.V.

Follitropin alfa

Neurostil 100mg Capsules

PA0749/164/001

Teva Pharma B.V.

Gabapentin

Olmesartan Medoxomil 10mg Film-Coated Tablets

PA2315/113/001

Accord Healthcare Ireland Ltd.

Olmesartan

Prasugrel Mylan 10mg Tablets

EU/1/18/1273/009

Mylan Pharmaceuticals Limited

Prasugrel

Raporsin 8mg Prolonged Release Tablets

PA2315/005/001

Accord Healthcare Ireland Ltd.

Doxazosin


Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 

 



« Back